Inovio Pharmaceuticals Inc. Stock Advances 21.1%, Outperforms Peers
Dow Jones2026/08/14 20:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. sailed 21.1% to $1.09 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.3% to 26,729.16 and Dow Jones Industrial Average falling 0.2% to 53,732.41.
This was the stock's fifth consecutive day of gains.
Inovio Pharmaceuticals Inc. closed 63.4% below its 52-week high of $2.98, which the company achieved on September 9th.
The stock outperformed some of its peers, as Johnson & Johnson fell 0.7% to $260.35, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. remained unchanged.
Trading volume totaled 12.1 million, compared to the 50-day average of 3.0 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 14, 2026 16:33 ET (20:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
US Treasury sell-off triggers massive waves in global bond markets! Global average yields approach the 4% threshold, Japan's 10-year hits a 30-year high
On Thursday, the global government bond sell-off intensified, pushing the average yield close to 4%, a level not seen since 2007.
Honda (HMC.US) firmly pursues the "ditch electric for hybrid" strategy, plans to invest $2.5 billion to build a new hybrid car factory in the US
Honda plans to build a new hybrid vehicle manufacturing plant in Ohio, USA.
Crypto prices
More
